0 0 0
Dieser Online-Shop verwendet Cookies für ein optimales Einkaufserlebnis. Dabei werden beispielsweise die Session-Informationen oder die Spracheinstellung auf Ihrem Rechner gespeichert. Ohne Cookies ist der Funktionsumfang des Online-Shops eingeschränkt. Sind Sie damit nicht einverstanden, klicken Sie bitte hier.
Histopathology Reporting

Boyle, Allen Histopathology Reporting

Guidelines for Surgical Cancer

ISBN: 978-3-030-27827-4

Auflage: 4th Ed.

Erscheinungsdatum: Dezember 2019

Einband: Hardcover

Seitenzahl: 507 p.

Illustrationen: 125 ill.

Verlag: Springer

Noch nicht erschienen, wir merken Ihre Bestellung vor

Beschreibung

  • Includes 8th edition TNM and WHO classifications of cancers
  • Explains key epidemiological, clinical, investigative, pathological, prognostic and treatment issues
  • Highlights new clinical procedures and ancillary laboratory techniques

This book is an easily comprehensible and practicable framework for standardised histopathology reports in surgical cancer. The pathological features of the common carcinomas are detailed and non-carcinomatous malignancies are also summarised. 8th edition TNM and WHO classifications of cancers are incorporated, with comments on any associated pathology, diagnostic clues and prognostic criteria supplemented visually by line diagrams.

Each chapter’s introduction gives epidemiological, clinical, investigative and treatment summary details. Other pathology includes updated immunophenotypic expression and molecular techniques. The impact of these ancillary investigations on diagnosis, and as biomarkers of prognosis and prediction of response to treatment is summarised, as is the effect of adjuvant treatments on cancers. Experience based clues are given throughout as aids to tumour typing, grading, staging, and gauging prognosis and response to treatment.

Histopathology Reporting: Guidelines for Surgical Cancer, Fourth Edition is invaluable for trainee and consultant diagnostic histopathologists all over the world, equipping the reader to produce high quality, clinically appropriate histopathology reports, and to participate in contemporary multidisciplinary team management of patients with surgical cancer.